• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 4: Robertson Lindon G sold $2,186,338 worth of shares (18,331 units at $119.27), decreasing direct ownership by 16% to 95,934 units (withholding tax)

    11/19/21 4:12:34 PM ET
    $BRKS
    Industrial Machinery/Components
    Technology
    Get the next $BRKS alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
    1. Name and Address of Reporting Person*
    Robertson Lindon G

    (Last) (First) (Middle)
    C/O BROOKS AUTOMATION, INC.
    15 ELIZABETH DRIVE

    (Street)
    CHELMSFORD MA 01824

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Brooks Automation, Inc. [ BRKS ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    EVP & Chief Financial Officer
    3. Date of Earliest Transaction (Month/Day/Year)
    11/17/2021
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 11/17/2021 S 14,460(1) D $119.27(2) 99,805 D
    Common Stock 11/17/2021 S 3,871(3) D $119.27(2) 95,934 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Represents the sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 15, 2021 of 33,745 performance-based units held by the reporting person and previously reported on Form 4.
    2. Represents the weighted average price for shares sold between November 16, 2021 and November 17, 2021 at a range between $114.73 and $121.43. The reporting person will provide to the Securities and Exchange Commission, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price.
    3. Represents the sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 15, 2021 of 9,267 restricted stock units from three grants held by the reporting person and previously reported on Form 4.
    Remarks:
    /s/ Jason W. Joseph, Attorney-in-fact for Lindon G. Robertson 11/19/2021
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $BRKS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BRKS

    DatePrice TargetRatingAnalyst
    11/17/2021$139.00 → $155.00Buy
    Needham
    11/17/2021$146.00 → $132.00Overweight
    Keybanc
    11/11/2021$100.00 → $120.00Neutral
    Citigroup
    11/10/2021$121.00 → $139.00Buy
    Needham
    9/7/2021$115.00 → $146.00Overweight
    Keybanc
    8/6/2021$130.00 → $114.00Buy
    Needham
    More analyst ratings

    $BRKS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Needham reiterated coverage on Brooks Automation with a new price target

      Needham reiterated coverage of Brooks Automation with a rating of Buy and set a new price target of $155.00 from $139.00 previously

      11/17/21 6:08:56 AM ET
      $BRKS
      Industrial Machinery/Components
      Technology
    • Keybanc reiterated coverage on Brooks Automation with a new price target

      Keybanc reiterated coverage of Brooks Automation with a rating of Overweight and set a new price target of $132.00 from $146.00 previously

      11/17/21 4:42:32 AM ET
      $BRKS
      Industrial Machinery/Components
      Technology
    • Citigroup reiterated coverage on Brooks Automation with a new price target

      Citigroup reiterated coverage of Brooks Automation with a rating of Neutral and set a new price target of $120.00 from $100.00 previously

      11/11/21 10:07:00 AM ET
      $BRKS
      Industrial Machinery/Components
      Technology

    $BRKS
    SEC Filings

    See more
    • Brooks Automation, Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits

      8-K - Azenta, Inc. (0000933974) (Filer)

      12/1/21 8:15:39 AM ET
      $BRKS
      Industrial Machinery/Components
      Technology
    • SEC Form 10-K filed by Brooks Automation, Inc.

      10-K - Brooks Automation, Inc. (0000933974) (Filer)

      11/24/21 9:17:52 AM ET
      $BRKS
      Industrial Machinery/Components
      Technology
    • Brooks Automation, Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Brooks Automation, Inc. (0000933974) (Filer)

      11/10/21 4:35:48 PM ET
      $BRKS
      Industrial Machinery/Components
      Technology

    $BRKS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed

      SC 13G - Brooks Automation, Inc. (0000933974) (Subject)

      2/11/21 3:13:09 PM ET
      $BRKS
      Industrial Machinery/Components
      Technology
    • SEC Form SC 13G/A filed

      SC 13G/A - Brooks Automation, Inc. (0000933974) (Subject)

      2/10/21 10:39:37 AM ET
      $BRKS
      Industrial Machinery/Components
      Technology

    $BRKS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Azenta Announces Fiscal 2022 Fourth Quarter and Full Year Earnings Conference Call and Webcast

      CHELMSFORD, Mass., Nov. 7, 2022 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) will announce fiscal fourth quarter and full year 2022 earnings which ended on September 30, 2022 on Monday, November 14, 2022 after the market closes. The Company will host a conference call and live webcast to discuss its financial results on the same day, Monday, November 14, 2022 at 4:30 p.m. Eastern Time.  To participate in the conference call, please dial 800-936-4761 for domestic callers and +1-212-231-2922 for international callers. Analysts, investors and members of the media can access the live webcast via the Azenta website at https://investors.azenta.com/events.  A replay will be available beginning at 8:3

      11/7/22 4:38:00 PM ET
      $AZTA
      $BRKS
      Industrial Machinery/Components
      Technology
    • Azenta Announces Completion of B Medical Systems Acquisition

      CHELMSFORD, Mass., Oct. 3, 2022 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today announced that it has closed its previously announced acquisition of B Medical Systems S.á r.l and its subsidiaries ("B Medical"), a market leader in temperature-controlled storage and transportation solutions that enables the delivery of life-saving treatments to more than 150 countries worldwide. This acquisition complements Azenta's cold chain capabilities, adding differentiated solutions for reliable and traceable transport of temperature-sensitive specimens. B Medical, headquartered in Hosingen, Luxembourg, is one of the leading vaccine cold chain providers serving primarily fast-growing emerging markets, w

      10/3/22 4:05:00 PM ET
      $AZTA
      $BRKS
      Industrial Machinery/Components
      Technology
    • Azenta to Participate in the Baird 2022 Global Healthcare Conference

      CHELMSFORD, Mass., Sept. 6, 2022 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today announced that Company management will participate in the Baird 2022 Global Healthcare Conference in New York City, on Wednesday, September 14, 2022, which includes a presentation beginning at 9:40 am ET. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event. About Azenta Life Sciences Azenta, Inc. (NASDAQ:AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain

      9/6/22 4:05:00 PM ET
      $AZTA
      $BRKS
      Industrial Machinery/Components
      Technology

    $BRKS
    Leadership Updates

    Live Leadership Updates

    See more
    • Azenta Life Sciences Names Matthew McManus Chief Operating Officer

      CHELMSFORD, Mass., Jan. 6, 2022 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today announced that it has appointed Matthew McManus Chief Operating Officer effective January 17th.  In this newly created role, Dr. McManus will oversee Life Sciences Products, Services, and all commercial operations of the business and will report directly to the CEO. "We are excited to have Matt join the Company as our COO," said Steve Schwartz, President and CEO of Azenta. "Matt brings decades of expertise in life sciences. His depth of knowledge and valuable perspective will enhance our leadership position in the markets we serve." Dr. McManus joins Azenta with over 25 years of experience in the life s

      1/6/22 4:05:00 PM ET
      $AZTA
      $BRKS
      Industrial Machinery/Components
      Technology

    $BRKS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Jarzynka David sold $1,228,883 worth of shares (10,216 units at $120.29), decreasing direct ownership by 18% to 46,315 units

      4 - Brooks Automation, Inc. (0000933974) (Issuer)

      11/22/21 4:16:54 PM ET
      $BRKS
      Industrial Machinery/Components
      Technology
    • SEC Form 4: Joseph Jason sold $1,036,933 worth of shares (8,694 units at $119.27), decreasing direct ownership by 9% to 89,850 units to cover withholding tax

      4 - Brooks Automation, Inc. (0000933974) (Issuer)

      11/19/21 4:16:49 PM ET
      $BRKS
      Industrial Machinery/Components
      Technology
    • SEC Form 4: Vacha Robin sold $1,831,384 worth of shares (15,368 units at $119.17), decreasing direct ownership by 40% to 22,932 units (tax withholding)

      4 - Brooks Automation, Inc. (0000933974) (Issuer)

      11/19/21 4:15:33 PM ET
      $BRKS
      Industrial Machinery/Components
      Technology

    $BRKS
    Financials

    Live finance-specific insights

    See more
    • Azenta Announces Fiscal 2022 Fourth Quarter and Full Year Earnings Conference Call and Webcast

      CHELMSFORD, Mass., Nov. 7, 2022 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) will announce fiscal fourth quarter and full year 2022 earnings which ended on September 30, 2022 on Monday, November 14, 2022 after the market closes. The Company will host a conference call and live webcast to discuss its financial results on the same day, Monday, November 14, 2022 at 4:30 p.m. Eastern Time.  To participate in the conference call, please dial 800-936-4761 for domestic callers and +1-212-231-2922 for international callers. Analysts, investors and members of the media can access the live webcast via the Azenta website at https://investors.azenta.com/events.  A replay will be available beginning at 8:3

      11/7/22 4:38:00 PM ET
      $AZTA
      $BRKS
      Industrial Machinery/Components
      Technology
    • Azenta Life Sciences Reports Results of Third Quarter of Fiscal 2022, Ended June 30, 2022

      CHELMSFORD, Mass., Aug. 9, 2022 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today reported financial results for the third quarter ended June 30, 2022. Quarter Ended Dollars in millions, except per share data June 30,  March 31,  June 30,  Change 2022 2022 2021 Prior Qtr. Prior Yr. Revenue from Continuing Operations $ 133 $ 146 $ 129 (9) % 3 % Life Sciences Products $ 47 $ 54 $ 49 (12) % (3) % Life Sciences Services $ 85 $ 92 $ 80 (7) % 6 % Diluted EPS Continuing Operations $ (0.09) $ (0.02) $ (0.02) nm nm Diluted EPS Total $ (0.13) $ 28.28 $ 0.53 nm nm Non-GAAP Diluted EPS Continuing Operations $ 0.12 $ 0.12 $ 0.10 0 % 14 % Adjusted EBITDA Continuing Operations $ 14 $ 19 $ 19 (29) % (26) % M

      8/9/22 4:20:00 PM ET
      $AZTA
      $BRKS
      Industrial Machinery/Components
      Technology
    • Azenta Announces Agreement to Acquire B Medical Systems

      Enhances Azenta's Leadership Position in Cold Chain Solutions and End-to-End Sample Management CHELMSFORD, Mass., Aug. 8, 2022 /PRNewswire/ -- Azenta, Inc. (NASDAQ:AZTA) today announced that it has entered into a definitive agreement to acquire B Medical Systems S.á r.l and its subsidiaries ("B Medical"), a market leader in temperature-controlled storage and transportation solutions that enables the delivery of life-saving treatments across the globe. The cash purchase price to be paid at closing will be approximately €410 million. Additional cash consideration, up to €50 million, may be paid upon achievement of certain future performance milestones. The transaction is expected to close in O

      8/8/22 4:05:00 PM ET
      $AZTA
      $BRKS
      Industrial Machinery/Components
      Technology